Status:
COMPLETED
Observational Cohort Study of TachoSil (TC-018-IN)
Lead Sponsor:
Nycomed
Conditions:
Blood Loss, Surgical
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this study is to collect information, after exposure to TachoSil ®, of all thromboembolic events, immunological events and drug interactions leading to thromboembolic events or major bl...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All subjects, treated with TachoSil ® by the participating physicians, will be registered with a set of basic data from their already existing data (i.e. no additional diagnostic procedures will be performed).
- Subjects who will provide their written informed consent to use existing data, allow direct access to data and data processing.
Exclusion
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00285623
Start Date
December 1 2005
End Date
July 1 2008
Last Update
May 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nycomed
Roskilde, Denmark, 4000